BioVie Presents Data for NE3107 at 2023 International Congre

28.08.2023 - New preclinical data characterizing NE3107 mechanism of action featured in oral presentationPhamacokinetic data from Phase 2a study supports potential co-administration of NE3107 with carbidopa/levodopaSeparate analysis of Phase 2a study data shows ... Seite 1

Related Keywords

Copenhagen , Køavn , Denmark , Clarence Ahlem , Movement Disorders , Biovie Inc , Nasdaq , International Congress , Vie Inc , Denmark August , Inflammatory Treatment , Motor Activity , Neurodegenerative Features , Marmoset Monkey Model , Christopherl Reading , Biovie Registereda Chart , Iovie Registereda Kurs , Iovie Registereda Aktie ,